LFCR

$6.42+0.47%visit website

LIFECORE BIOMEDICAL, INC. \DE\

Market Cap

$241M

Live price × Finnhub shares (2026-09-20)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

1.01

60mo monthly vs SPY

P/E (TTM)

—

No recent SEC filing data

P/S (TTM)

—

No recent SEC filing data

P/B

—

No recent SEC filing data

EV/EBITDA (TTM)

—

No recent SEC filing data

Loading…

Financial Statements

USD thousands	Q4 FY2025 May 25, 2025	Q1 FY2026 Sep 30, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026
Revenue	36,444	31,109	23,193	34,167
Cost of revenue	22,462	23,318	18,731	22,092
Gross profit	13,982	7,791	4,462	12,075
Research & development	2,103	1,963	1,217	1,537
Selling, general & administrative	8,980	8,895	7,917	7,971
Operating income	5,327	(3,067)	(4,672)	2,567
Interest expense	5,727	6,384	7,348	7,751
Pretax income	(1,114)	(9,658)	(14,937)	(6,133)
Income tax	33	333	43	23
Net income	(1,147)	(9,991)	(14,980)	(6,156)
EPS (basic) ($)	(0.06)	(0.29)	(0.43)	(0.19)
EPS (diluted) ($)	(0.06)	(0.29)	(0.43)	(0.19)
Weighted avg. shares (basic)	37,008	37,403	37,477	37,575
Weighted avg. shares (diluted)	37,008	37,403	37,477	37,575

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 5, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 4 quarters. 59 more quarters, back to Aug 2010, with Tormere Pro.

Corporate Events (8-K)

12 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 20, 2026 accepted 4:30 PM ET	8.01Other events	Document SEC ↗
Sep 29, 2026 accepted 4:12 PM ET	1.01Material agreement	Document SEC ↗
Sep 28, 2026 accepted 8:53 AM ET	1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Aug 5, 2026 accepted 7:17 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jul 2, 2026 accepted 5:17 PM ET	7.01Reg FD disclosure	Document SEC ↗
Jun 5, 2026 accepted 4:10 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 6, 2026 accepted 7:17 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 16, 2026 accepted 8:08 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 5, 2026 accepted 4:33 PM ET	5.08Director nominations	Document SEC ↗
Jan 16, 2026 accepted 4:29 PM ET	5.02Officer / director change	Document SEC ↗